-
401por Gupta, Shaloo, Chang, Nai-Chung N, Stempniewicz, Nikita, Tirupati, Chenchu Bhavani K, Coronado, Gregorio, Lynch, Julie A, Hogea, Cosmina, Mulvihill, Emily, Gagner, Jason, DuVall, Scott L“…DuVall, PhD, Alnylam Pharmaceuticals, Inc.: Grant/Research Support|Astellas Pharma, Inc.: Grant/Research Support|AstraZeneca Pharmaceuticals LP: Grant/Research Support|Biodesix: Grant/Research Support|Celgene Corporation: Grant/Research Support|Cerner Enviza: Grant/Research Support|GSK: Grant/Research Support|Janssen Pharmaceuticals, Inc.: Grant/Research Support|Novartis International AG: Grant/Research Support|Parexel International Corporation: Grant/Research Support…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
402
-
403por Salinas-Martínez, Ana María, Rodríguez-Vidales, Edgar P., Garza-Carrillo, Denise, Robles-Rodríguez, Olivia A., Oca-Luna, Roberto Montes de, Marroquín-Escamilla, Alma Rosa“…The fully ChAdOx1 (AstraZeneca) scheme reached the maximum effectiveness in hospitalization (80%, 95%CI 69, 87) and the fully BNT162b2 (Pfizer) scheme the maximum effectiveness in severity (81%, 95%CI 64, 90). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
404por Sedighi, Behnaz, Haghdoost, Aliakbar, Jangipour Afshar, Parya, Abna, Zohre, Bahmani, Shamimeh, Jafari, Simin“…Among all COVID-19 vaccines, AstraZeneca had the most common side effects, so people must be aware of them before vaccination. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
405por Giai, Constanza, Salassa, Betiana Nebaí, Zarelli, Valeria Eugenia, Bello, Oscar Daniel, Vanrell, María Cristina, Ojeda, Diego Sebastian, Gamarnik, Andrea, Colombo, María Isabel“…In the case of those vaccinated with AstraZeneca, the percentage was 80% (n = 15) whereas this value was reduced to only 25% (n = 16) in persons that received Sinopharm. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
406“…Efflux models were built with ADMET Predictor neural net, support vector machine, kernel partial least squares, and multiple linear regression engines, as well as SIMCA-P+ partial least squares, and random forest from Pipeline Pilot as implemented by AstraZeneca, using molecular descriptors from SimulationsPlus and AstraZeneca. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
407por Arvidsson, Per I“…In 2006, he joined AstraZeneca R&D Södertälje (Sweden). After 1-year in-house training for future leaders in drug discovery and development, he became team leader in Medicinal Chemistry in 2007. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
408por Doroftei, Bogdan, Ciobica, Alin, Ilie, Ovidiu-Dumitru, Maftei, Radu, Ilea, Ciprian“…We concluded that from all eleven vaccines, three had an efficacy >90% (Pfizer–BioNTech (~95%), Moderna (~94%), and Sputnik V (~92%)) except for Oxford–AstraZeneca (~81%). However, Moderna, Sputnik V, and Oxford–AstraZeneca also alleviate severe adverse reactions, whereas in Pfizer–BioNTech this was not revealed. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
409por Le Daré, Brendan, Bacle, Astrid, Lhermitte, Roxane, Lesourd, François, Lurton, Yves“…The objective of this study is to determine which medical devices allow the extraction of the maximum number of doses from different vaccine vials (Pfizer-BioNTech, AstraZeneca, Moderna and Johnson & Johnson vaccines) by analyzing all the factors involved in the preparation of the injected doses. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
410por Zahid, Muhammad Nauman“…There are four vaccines (Sinopharm, Pfizer—BioNTech, Sputnik, and AstraZeneca) available in Bahrain. This project aimed to study the most common side effects resulting from the first and second doses of these four vaccines. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
411“…Its effects are substantial: most respondents reported a willingness to wait months for their preferred vaccine rather than receive either the AstraZeneca or Johnson & Johnson vaccine immediately. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
412“…In this paper, we report the case of a 55-year-old male patient who developed a myasthenic crisis after receiving the first dose of the ChAdOx1-S (recombinant) vaccine (AstraZeneca batch number 210157; AstraZeneca plc, Cambridge, United Kingdom). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
413por Abbasi, Safwan, Alsermani, Anas, Alsegayyir, Abdulaziz, Altahan, Talal, Alsermani, Maamoun, Almustanyir, Sami“…Adenoviral vector-based vaccines, namely the ChAdOx1-S vaccine (AstraZeneca, Cambridge, UK) and Ad26.COV2.S (Janssen; Johnson & Johnson, New Brunswick, NJ, USA), have been associated with a possibly fatal adverse event known as vaccine-induced thrombotic thrombocytopenia (VITT), wherein thrombi form in unusual sites, mainly the cerebral and splanchnic veins. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
414por Guzmán-López, Santos, Darwich-Salazar, Armine, Bocanegra-Ibarias, Paola, Salas-Treviño, Daniel, Flores-Treviño, Samantha, Pérez-Alba, Eduardo, Nuzzolo-Shihadeh, Laura M., Pérez-Rodríguez, Edelmiro, Camacho-Ortiz, Adrián“…Of those, 72.7% had CanSino Bio, 10.3% Pfizer, 8.4% AstraZeneca, 1.2% Moderna, and 2.7% others. Symptomatic breakthrough infections were recorded in those vaccinated with CanSino Bio (4.1%), AstraZeneca (2.1%), and Pfizer (2.2%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
415por Fantin, Francesco, Frosolini, Andrea, Tundo, Isabella, Inches, Ingrid, Fabbris, Cristoforo, Spinato, Giacomo, de Filippis, Cosimo“…Here, we report a singular case of smell and taste disorder associated with tinnitus that occurred after Oxford-AstraZeneca vaccination together with a review of the available literature. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
416“…BACKGROUND: Vaccines for coronavirus disease 2019 (COVID-19) include ChAdOx1-SARS-COV-2 (AstraZeneca), Ad26.COV2.S (Janssen), mRNA-1273 (Moderna), BNT162b2 (Pfizer), BBIBP-CorV (Sinopharm), CoronaVac (Sinovac), and Bharat Biotech BBV152 (Covaxin). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
417por Islas-Vazquez, Lorenzo, Cruz-Aguilar, Marisa, Velazquez-Soto, Henry, Jiménez-Corona, Aida, Pérez-Tapia, Sonia Mayra, Jimenez-Martinez, Maria C.“…We included samples from 69 volunteers inoculated with the Pfizer-BioNTech (BNT162b2), Astra Zeneca (AZD1222 Covishield), or Sputnik V (Gam-COVID-Vac) vaccines. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
418por Hammad, Noha M., Kadry, Heba M., Malek, Mai M., Bahgat, Shereen Mohamed, Abdelsalam, Noha M., Afifi, Amira Hamed Mohamed, Abo-alella, Doaa Alhussein“…Conclusions: The Oxford–AstraZeneca vaccine is generally safe and provides a highly effective long-term humoral immune response against the Delta and Omicron variants of SARS-CoV-2.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
419por Wolszczak Biedrzycka, Blanka, Bieńkowska, Anna, Smolińska-Fijołek, Elwira, Biedrzycki, Grzegorz, Dorf, Justyna“…RESULTS: The study revealed that persons who received three doses of the Pfizer/BioNTech vaccine had significantly higher antibody titers than those who received two doses of AstraZeneca and a booster dose of Pfizer/BioNTech.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
420por Albakri, Khaled, Khaity, Abdulrhman, Atwan, Hany, Saleh, Othman, Al-Hajali, Momen, Cadri, Shirin, Diab, Rehab Adel, Albazee, Ebraheem, Negida, Ahmed“…Also, the majority of the cases were reported after the first dose, and most cases were after Pfizer, AstraZeneca, and Sputnik V vaccines, respectively. The patients who were treated with corticosteroids, IVIG, and anti-viral drugs, showed marked recovery afterward. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto